Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Optimisation of Key Abiotic Factors of PAH (Naphthalene, Phenanthrene and Anthracene) Biodegradation Process by a Bacterial Consortium.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- الموضوع:
- نبذة مختصرة :
The aim of this work was to determine the optimum values for the biodegradation process of six abiotic factors considered very influential in this process. The optimisation of a polycyclic aromatic hydrocarbon (naphthalene, phenanthrene and anthracene) biodegradation process was carried out with a degrading bacterial consortium C2PL05. The optimised factors were the molar ratio of carbon/nitrogen/phosphorus (C/N/P), the nitrogen source, the iron source, the iron concentration, the pH and the carbon source. Each factor was optimised applying three different treatments during 168 h, analysing cell density by spectrophotometric absorbance at 600 nm and PAH depletion by HPLC. To determine the optimum values of the factors, an analysis of variance was performed using the cell density increments and biotic degradation constants, calculated for each treatment. The most effective values of each factor were: a C/N/P molar ratio of 100:21:16, NaNO as nitrogen source, Fe(SO) as iron source using a concentration of 0.1 mmol l, a pH of 7.0 and a mixture of glucose and PAHs as carbon source. Therefore, high concentrations of nutrients and soluble forms of nitrogen and iron at neutral pH favour the biodegradation. Also, the addition of glucose to PAHs as carbon source increased the number of total microorganism and enhanced PAH biodegradation due to the augmentation of PAH degrader microorganisms. It is also important to underline that the statistical treatment of data and the combined study of the increments of the cell density and the biotic biodegradation constant have facilitated the accurate interpretation of the optimisation results. For an optimum bioremediation process, it is very important to perform these previous bioassays to decrease the process development time and, therefore, the costs. [ABSTRACT FROM AUTHOR]
No Comments.